Guy Reed, MD, began more than a decade ago to research a safer, more effective therapy for dissolving blood clots, which are the cause of most strokes. The outcome of that research is a novel thrombus (blood clot) dissolving agent, TS23, which is currently undergoing clinical trials.
UTRF News
Cherokee Farm Innovation Campus – Planting Ideas, Growing Momentum
Article courtesy of Tennessee Alumnus About 10 years ago, Cherokee Farm Innovation Campus existed only in concept—as a place where ideas would be planted so that innovation could bloom. Cherokee Farm was imagined as a state-of-the-art science and technology research park focused on solving problems of national significance. The idea was the product of two (read more)
Finalists for top awards at Knoxville’s upcoming Innov865 Startup Day announced
By Tom Ballard,Chief Alliance Officer, PYA The Innova865 Alliance has announced the finalists for the two top awards that will be given at the end of this year’s Knoxville Startup Day set for September 22 at the Bijou Theater. Three finalists have been named for the “Traction Award,” while six start-ups will present their new companies (read more)